Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

Influenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Sánchez-de Prada, Silvia Rojo-Rello, Marta Domínguez-Gil, Eduardo Tamayo-Gómez, Raúl Ortiz de Lejarazu-Leonardo, José María Eiros, Iván Sanz-Muñoz
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
age
sex
Acceso en línea:https://doaj.org/article/871c36e087884470a75a19a47cee3f9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:871c36e087884470a75a19a47cee3f9f
record_format dspace
spelling oai:doaj.org-article:871c36e087884470a75a19a47cee3f9f2021-11-11T09:02:48ZInfluenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses1664-302X10.3389/fmicb.2021.737216https://doaj.org/article/871c36e087884470a75a19a47cee3f9f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.737216/fullhttps://doaj.org/toc/1664-302XInfluenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria and Yamagata; and trivalent vaccines, that only contain one of these lineages, are still in use. For that reason, if during an epidemic, the lineage not included in the vaccine predominates, a mismatch would occur, and the vaccine effectiveness will be very poor. In this work, we evaluated the cross-protection given by the trivalent Influenza vaccine and compared serological profiles based on age, sex, and the type of vaccine used. We performed a retrospective analysis of serum samples obtained before and after seasonal influenza vaccination during 20 seasons (1998–2018). The results showed that heterotypic reactivity between both influenza B lineages is common, but always lower than the homologous response. Age is a relevant factor for this cross-reactivity between both lineages, while the sex and the type of vaccine not. Vaccination with trivalent influenza vaccines elicits cross-reactive antibodies against both lineages, however, this response might not be enough to provide an appropriate serological protection in case of mismatch.Laura Sánchez-de PradaLaura Sánchez-de PradaSilvia Rojo-RelloSilvia Rojo-RelloMarta Domínguez-GilMarta Domínguez-GilEduardo Tamayo-GómezRaúl Ortiz de Lejarazu-LeonardoJosé María EirosJosé María EirosJosé María EirosIván Sanz-MuñozFrontiers Media S.A.articleinfluenza Bcross-immunityageelderlysexvaccinesMicrobiologyQR1-502ENFrontiers in Microbiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic influenza B
cross-immunity
age
elderly
sex
vaccines
Microbiology
QR1-502
spellingShingle influenza B
cross-immunity
age
elderly
sex
vaccines
Microbiology
QR1-502
Laura Sánchez-de Prada
Laura Sánchez-de Prada
Silvia Rojo-Rello
Silvia Rojo-Rello
Marta Domínguez-Gil
Marta Domínguez-Gil
Eduardo Tamayo-Gómez
Raúl Ortiz de Lejarazu-Leonardo
José María Eiros
José María Eiros
José María Eiros
Iván Sanz-Muñoz
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
description Influenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria and Yamagata; and trivalent vaccines, that only contain one of these lineages, are still in use. For that reason, if during an epidemic, the lineage not included in the vaccine predominates, a mismatch would occur, and the vaccine effectiveness will be very poor. In this work, we evaluated the cross-protection given by the trivalent Influenza vaccine and compared serological profiles based on age, sex, and the type of vaccine used. We performed a retrospective analysis of serum samples obtained before and after seasonal influenza vaccination during 20 seasons (1998–2018). The results showed that heterotypic reactivity between both influenza B lineages is common, but always lower than the homologous response. Age is a relevant factor for this cross-reactivity between both lineages, while the sex and the type of vaccine not. Vaccination with trivalent influenza vaccines elicits cross-reactive antibodies against both lineages, however, this response might not be enough to provide an appropriate serological protection in case of mismatch.
format article
author Laura Sánchez-de Prada
Laura Sánchez-de Prada
Silvia Rojo-Rello
Silvia Rojo-Rello
Marta Domínguez-Gil
Marta Domínguez-Gil
Eduardo Tamayo-Gómez
Raúl Ortiz de Lejarazu-Leonardo
José María Eiros
José María Eiros
José María Eiros
Iván Sanz-Muñoz
author_facet Laura Sánchez-de Prada
Laura Sánchez-de Prada
Silvia Rojo-Rello
Silvia Rojo-Rello
Marta Domínguez-Gil
Marta Domínguez-Gil
Eduardo Tamayo-Gómez
Raúl Ortiz de Lejarazu-Leonardo
José María Eiros
José María Eiros
José María Eiros
Iván Sanz-Muñoz
author_sort Laura Sánchez-de Prada
title Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
title_short Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
title_full Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
title_fullStr Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
title_full_unstemmed Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
title_sort influenza b lineages have more in common than meets the eye. trivalent influenza vaccines trigger heterotypic antibodies against both influenza b viruses
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/871c36e087884470a75a19a47cee3f9f
work_keys_str_mv AT laurasanchezdeprada influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT laurasanchezdeprada influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT silviarojorello influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT silviarojorello influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT martadominguezgil influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT martadominguezgil influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT eduardotamayogomez influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT raulortizdelejarazuleonardo influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT josemariaeiros influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
AT ivansanzmunoz influenzablineageshavemoreincommonthanmeetstheeyetrivalentinfluenzavaccinestriggerheterotypicantibodiesagainstbothinfluenzabviruses
_version_ 1718439325861937152